Epidemiology and survival of patients with spinal meningiomas: A SEER analysis

Eur J Surg Oncol. 2021 Sep;47(9):2340-2345. doi: 10.1016/j.ejso.2021.01.012. Epub 2021 Jan 22.

Abstract

Background: The objective of this study is to determine the population-based estimates of the epidemiology, incidence, and outcomes of spinal meningiomas.

Methods: The data of patients with spinal meningiomas diagnosed between 2004 and 2016 were extracted from the SEER database. Descriptive analyses were conducted to evaluate the distribution and tumor-related characteristics of patients with spinal meningiomas. Multivariate logistic regression analysis was performed to predict which patients were inclined to be diagnosed with borderline or malignant spinal meningiomas. Possible prognostic indicators were analyzed by Kaplan-Meier curves and the Cox proportional hazards model.

Results: The age-adjusted incidence rate was 0.37 cases per 1,000,000 person-years between 2004 and 2016. Spinal meningiomas represented 4.25% of all meningiomas. A total of 4204 patients with spinal meningiomas were included in our study. Most of the patients were white and diagnosed at 60-69 years of age, and the female:male ratio was 4:1. Most of the tumors were benign and less than 3 cm in size. The most common pathological type was psammomatous meningioma. Surgery was the first choice of treatment for patients with spinal meningiomas. Male and pediatric patients were more vulnerable to borderline or malignant spinal meningiomas. Survival analysis showed that married, female, and younger patients with benign meningiomas had better overall survival than their counterparts.

Conclusion: Spinal meningiomas are relatively rare lesions with a favorable prognosis. Psammomatous meningioma is the most common subtype. Male and pediatric patients are more frequently diagnosed with borderline or malignant spinal meningiomas. Surgery is the primary choice of treatment.

Keywords: CNS disease; Epidemiology; SEER Program; Spinal meningioma; Survival.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Incidence
  • Kaplan-Meier Estimate
  • Male
  • Marital Status
  • Meningeal Neoplasms / epidemiology*
  • Meningeal Neoplasms / mortality
  • Meningeal Neoplasms / pathology
  • Meningioma / epidemiology*
  • Meningioma / mortality
  • Meningioma / pathology
  • Middle Aged
  • SEER Program
  • Sex Factors
  • Spinal Cord Neoplasms / epidemiology*
  • Spinal Cord Neoplasms / mortality
  • Spinal Cord Neoplasms / pathology
  • Survival Rate
  • United States / epidemiology
  • Young Adult